Open-label Study to Evaluate Safety, Tolerability and PK of BHV-0223 in ALS
Conditions: Amyotrophic Lateral Sclerosis; ALS; Lou Gehrig Disease; Lou Gehrig's Disease; Lou-Gehrigs Disease; Motor Neuron Disease, Amyotrophic Lateral Sclerosis Intervention: Drug: BHV-0223 Sponsors: Biohaven Pharmaceutical Holding Company Ltd.; Cognitive Research Corporation (CRC) Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials